NxStage Medical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-05-28: Reporting owner MOORE CRAIG W; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-05-28: Reporting owner Utterberg David S; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-05-28: Reporting owner SILVERSTEIN JONATHAN; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-05-28: Reporting owner REID PERPER; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-05-28 | MOORE CRAIG W Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $3.38 exercise price | 2009-06-01 | |
| 2009-05-28 | Utterberg David S Director, 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $3.38 exercise price | 2009-06-01 | |
| 2009-05-28 | SILVERSTEIN JONATHAN Director, 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $3.38 exercise price | 2009-06-01 | |
| 2009-05-28 | REID PERPER Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $3.38 exercise price | 2009-06-01 | |
| 2009-05-28 | LEWIS EARL R Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $3.38 exercise price | 2009-06-01 | |
| 2009-05-28 | Giannini Daniel A Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $3.38 exercise price | 2009-06-01 | |
| 2009-05-28 | CHAMBON PHILIPPE Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $3.38 exercise price | 2009-06-01 | |
| 2009-03-05 | Turk Joseph E Jr Officer (SVP Commercial Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +74,000 74,000 owned after | $2.11 exercise price | 2009-03-09 | |
| 2009-03-05 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +74,000 74,000 owned after | $2.11 exercise price | 2009-03-09 | |
| 2009-03-05 | Burbank Jeffrey H Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +206,500 206,500 owned after | $2.11 exercise price | 2009-03-09 | |
| 2009-03-05 | Webb Michael J. Officer (SVP, Quality & Regulatory) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,000 57,000 owned after | $2.11 exercise price | 2009-03-09 | |
| 2009-03-05 | Shea Thomas Officer (SVP Manufacturing Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,000 57,000 owned after | $2.11 exercise price | 2009-03-09 | |
| 2009-03-05 | Brown Robert S. Officer (Sr. Vice President, CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +74,000 74,000 owned after | $2.11 exercise price | 2009-03-09 |